TCT 2009

San Francisco, California; September 21-25

Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

SYMPLICITY I: One-Year Results Following Sympathetic Renal Denervation in Refractory Hypertension – Henry Krum
- Trial Summary
DEBATER: A Prospective Randomized Trial of Drug-Eluting vs. Bare-Metal Stents With or Without Abciximab in STEMI – Rolf Michels
- Trial Summary
HORIZONS-AMI: Two-Year Follow-up from a Prospective, Randomized Trial of Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors in STEMI – Gregg W. Stone
- Trial Summary
- Presentation Slides
HORIZONS-AMI Stent: Two-Year Follow-up from a Prospective, Randomized Trial of Paclitaxel-Eluting vs. Bare-Metal Stents in STEMI – Gregg W. Stone
- Trial Summary
- Presentation Slides
BCIS-1: A Prospective Randomized Trial of Intraaortic Balloon Pump Counterpulsation in High-Risk Patients Undergoing PCI – A. Simon Redwood
- Trial Summary
NORDIC-BALTIC BIFURCATION STUDY III: A Prospective Randomized Trial of Side Branch Dilatation Strategies in Patients with Coronary Bifurcation Lesions Undergoing Treatment with a Single Stent – Matti Jaakko Niemela
- Trial Summary
FAUST: A Prospective Randomized Trial of Ultrasound-Guided vs. Standard Femoral Arterial Access – Arnold Seto
- Trial Summary

CURRENT-PCI OASIS 7: A Prospective, Randomized, Placebo-Controlled Trial of Highvs. Standard-Dose Clopidogrel and High- vs. Low-Dose Aspirin in Patients Undergoing PCI for ACS – Shamir R. Mehta
- Trial Summary
COGENT: A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel – Deepak L. Bhatt
CHARISMA GENOMICS SUBSTUDY: Evaluation of the CYP2C19 Polymorphism in a Prospective, Randomized, Placebo-Controlled Trial of Chronic Clopidogrel Use for Primary and Secondary Prevention – Deepak L. Bhatt
- Presentation Slides
TRITON-TIMI 38 ECONOMIC SUBSTUDY: Cost-Effectiveness of Prasugrel vs. Clopidogrel from a Prospective Randomized Trial of Patients with ACS Undergoing PCI – David J. Cohen
- Presentation Slides
PLATO INVASIVE: A Prospective, Randomized, Placebo-Controlled Trial of Ticagrelor vs. Clopidogrel in Patients with ACS Managed with an Invasive Strategy – Christopher P. Cannon
- Presentation Slides
PROSPECT: A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque – Gregg W. Stone
- Presentation Slides

SPIRIT IV: A Prospective Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents – Gregg W. Stone
- Presentation Slides
COMPARE: A Prospective Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents – Peter C. Smits
- Trial Summary
ISAR-DESIRE 2: A Prospective Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents for Treatment of Restenosis of Sirolimus-Eluting Stents – Robert A. Byrne
- Trial Summary
- Presentation Slides
SIRTAX-LATE: Five-Year Clinical and Angiographic Follow-up from a Prospective Randomized Trial of Sirolimus-Eluting and Paclitaxel-Eluting Stents – Lorenz Räber
- Trial Summary